Hongwon Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hongwon Kim has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Jongpil Kim
Institute for Stem Cells and Regenerative Medicine (ISR) Department of Chemistry Dongguk University Seoul Republic of Korea
5 shared publications Saemin An
Institute for Stem Cell & Regenerative Medicine, Department of Chemistry, Dongguk University, Seoul, Republic of Korea
3 shared publicationsByounggook Cho
Department of Chemistry, Dongguk University, Jung-gu, Republic of Korea
2 shared publications- Byounggook Cho
Institute for Stem Cell & Regenerative Medicine, Department of Chemistry, Dongguk University, Seoul, Republic of Korea
2 shared publications Daeyeol Kwon
Institute for Stem Cell & Regenerative Medicine, Department of Chemistry, Dongguk University, Seoul, Republic of Korea
2 shared publications- Junyeop Kim
Laboratory of Stem Cells & Cell Reprogramming, Department of Chemistry and Biomedical Engineering, Dongguk University, Seoul, Republic of Korea
2 shared publications
Latest Publications
- 30 August 2025
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (2) , 786-801
Aberrant neural stem cell quiescence is the gateway to autism development linked to Arid1b
Autism spectrum disorder is a neurodevelopmental disorder with social communication deficits, repetitive behaviors, and restricted interests. While previous studies have demonstrated a close link between aberrant neurogenesis and the development of autism, a fundamental question remains unresolved: Does the anomalous neurogenesis observed in autism serve as a causative factor, and if so, could restoring aberrant neurogenesis alleviate autistic behaviors? In this study, we demonstrate that the manifestation of autistic behaviors can be caused by the aberrant activity of quiescent neural stem cells (qNSCs), resulting from the conditional deletion of Arid1b in adult brain NSCs. Particularly, increased H3K27me3 levels in qNSCs due to conditional Arid1b deficiency precipitated autism-related phenotypes, but rescuing this through H3K27me3 inhibition effectively reversed autistic-like phenotypes. Importantly, we also found quiescent like NSCs in humans carrying the ARID1B mutation, as well as in NSCs of sporadic autism patients. These results highlight the significant role of aberrant qNSCs associated with adult neurogenesis for autism development in adult brain, offering a novel avenue for potentially controlling qNSC activity as a therapeutic strategy for autism.
- 30 August 2025
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (2) , 786-801
Aberrant neural stem cell quiescence is the gateway to autism development linked to Arid1b
Autism spectrum disorder is a neurodevelopmental disorder with social communication deficits, repetitive behaviors, and restricted interests. While previous studies have demonstrated a close link between aberrant neurogenesis and the development of autism, a fundamental question remains unresolved: Does the anomalous neurogenesis observed in autism serve as a causative factor, and if so, could restoring aberrant neurogenesis alleviate autistic behaviors? In this study, we demonstrate that the manifestation of autistic behaviors can be caused by the aberrant activity of quiescent neural stem cells (qNSCs), resulting from the conditional deletion of Arid1b in adult brain NSCs. Particularly, increased H3K27me3 levels in qNSCs due to conditional Arid1b deficiency precipitated autism-related phenotypes, but rescuing this through H3K27me3 inhibition effectively reversed autistic-like phenotypes. Importantly, we also found quiescent like NSCs in humans carrying the ARID1B mutation, as well as in NSCs of sporadic autism patients. These results highlight the significant role of aberrant qNSCs associated with adult neurogenesis for autism development in adult brain, offering a novel avenue for potentially controlling qNSC activity as a therapeutic strategy for autism.
- Open Access
- 11 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
PTN activity in quiescent neural stem cells mediates Shank3 overexpression-induced manic behavior
Mania is a complex psychiatric disease characterized by hyperactivity, elevated mood and reduced anxiety. Despite extensive studies on the mechanism of the manic episodes, the molecular targets that control manic pathogenesis remain largely unclear. Here, through single-cell RNA sequencing (scRNA-seq) analysis, we show aberrant adult neurogenesis due to increased numbers of quiescent neural stem cells (qNSC) in a manic mouse model with Shank3 overexpression. Particularly, we found that the excessive Pleiotrophin (PTN), released by dysregulated qNSCs, is a key factor contributing to the manic-like phenotypes in Shank3-overexpressing mouse models. Pharmacological and molecular inhibition of PTN in qNSCs rescued aberrant neurogenesis and effectively alleviated the manic-like social deficits observed in Shank3-overexpressing mice. Taken together, our findings present an approach for modulating PTN activity in qNSCs, proposing it as a promising therapeutic target for manic development.
- 11 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
Open AccessPTN activity in quiescent neural stem cells mediates Shank3 overexpression-induced manic behavior
Mania is a complex psychiatric disease characterized by hyperactivity, elevated mood and reduced anxiety. Despite extensive studies on the mechanism of the manic episodes, the molecular targets that control manic pathogenesis remain largely unclear. Here, through single-cell RNA sequencing (scRNA-seq) analysis, we show aberrant adult neurogenesis due to increased numbers of quiescent neural stem cells (qNSC) in a manic mouse model with Shank3 overexpression. Particularly, we found that the excessive Pleiotrophin (PTN), released by dysregulated qNSCs, is a key factor contributing to the manic-like phenotypes in Shank3-overexpressing mouse models. Pharmacological and molecular inhibition of PTN in qNSCs rescued aberrant neurogenesis and effectively alleviated the manic-like social deficits observed in Shank3-overexpressing mice. Taken together, our findings present an approach for modulating PTN activity in qNSCs, proposing it as a promising therapeutic target for manic development.
- Open Access
- 9 August 2024
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 16, 1435445
Modeling APOE ε4 familial Alzheimer’s disease in directly converted 3D brain organoids
Brain organoids have become a valuable tool for studying human brain development, disease modeling, and drug testing. However, generating brain organoids with mature neurons is time-intensive and often incomplete, limiting their utility in studying age-related neurodegenerative diseases such as Alzheimer’s disease (AD). Here, we report the generation of 3D brain organoids from human fibroblasts through direct reprogramming, with simplicity, efficiency, and reduced variability. We also demonstrate that induced brain organoids from APOE ε4 AD patient fibroblasts capture some disease-specific features and pathologies associated with APOE ε4 AD. Moreover, APOE ε4-induced brain organoids with mutant APP overexpression faithfully recapitulate the acceleration of AD-related pathologies, providing a more physiologically relevant and patient-specific model of familial AD. Importantly, transcriptome analysis reveals that gene sets specific to APOE ε4 patient-induced brain organoids are highly similar to those of APOE ε4 post-mortem AD brains. Overall, induced brain organoids from direct reprogramming offer a promising approach for more efficient and controlled studies of neurodegenerative disease modeling.
- 9 August 2024
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 16, 1435445
Open AccessModeling APOE ε4 familial Alzheimer’s disease in directly converted 3D brain organoids
Brain organoids have become a valuable tool for studying human brain development, disease modeling, and drug testing. However, generating brain organoids with mature neurons is time-intensive and often incomplete, limiting their utility in studying age-related neurodegenerative diseases such as Alzheimer’s disease (AD). Here, we report the generation of 3D brain organoids from human fibroblasts through direct reprogramming, with simplicity, efficiency, and reduced variability. We also demonstrate that induced brain organoids from APOE ε4 AD patient fibroblasts capture some disease-specific features and pathologies associated with APOE ε4 AD. Moreover, APOE ε4-induced brain organoids with mutant APP overexpression faithfully recapitulate the acceleration of AD-related pathologies, providing a more physiologically relevant and patient-specific model of familial AD. Importantly, transcriptome analysis reveals that gene sets specific to APOE ε4 patient-induced brain organoids are highly similar to those of APOE ε4 post-mortem AD brains. Overall, induced brain organoids from direct reprogramming offer a promising approach for more efficient and controlled studies of neurodegenerative disease modeling.
- 20 April 2022
- Published by Springer Nature in Molecular Psychiatry
- Vol. 27 (6) , 2751-2765
Dormant state of quiescent neural stem cells links Shank3 mutation to autism development
Autism spectrum disorders (ASDs) are common neurodevelopmental disorders characterized by deficits in social interactions and communication, restricted interests, and repetitive behaviors. Despite extensive study, the molecular targets that control ASD development remain largely unclear. Here, we report that the dormancy of quiescent neural stem cells (qNSCs) is a therapeutic target for controlling the development of ASD phenotypes driven by Shank3 deficiency. Using single-cell RNA sequencing (scRNA-seq) and transposase accessible chromatin profiling (ATAC-seq), we find that abnormal epigenetic features including H3K4me3 accumulation due to up-regulation of Kmt2a levels lead to increased dormancy of qNSCs in the absence of Shank3. This result in decreased active neurogenesis in the Shank3 deficient mouse brain. Remarkably, pharmacological and molecular inhibition of qNSC dormancy restored adult neurogenesis and ameliorated the social deficits observed in Shank3-deficient mice. Moreover, we confirmed restored human qNSC activity rescues abnormal neurogenesis and autism-like phenotypes in SHANK3-targeted human NSCs. Taken together, our results offer a novel strategy to control qNSC activity as a potential therapeutic target for the development of autism.
- 20 April 2022
- Published by Springer Nature in Molecular Psychiatry
- Vol. 27 (6) , 2751-2765
Dormant state of quiescent neural stem cells links Shank3 mutation to autism development
Autism spectrum disorders (ASDs) are common neurodevelopmental disorders characterized by deficits in social interactions and communication, restricted interests, and repetitive behaviors. Despite extensive study, the molecular targets that control ASD development remain largely unclear. Here, we report that the dormancy of quiescent neural stem cells (qNSCs) is a therapeutic target for controlling the development of ASD phenotypes driven by Shank3 deficiency. Using single-cell RNA sequencing (scRNA-seq) and transposase accessible chromatin profiling (ATAC-seq), we find that abnormal epigenetic features including H3K4me3 accumulation due to up-regulation of Kmt2a levels lead to increased dormancy of qNSCs in the absence of Shank3. This result in decreased active neurogenesis in the Shank3 deficient mouse brain. Remarkably, pharmacological and molecular inhibition of qNSC dormancy restored adult neurogenesis and ameliorated the social deficits observed in Shank3-deficient mice. Moreover, we confirmed restored human qNSC activity rescues abnormal neurogenesis and autism-like phenotypes in SHANK3-targeted human NSCs. Taken together, our results offer a novel strategy to control qNSC activity as a potential therapeutic target for the development of autism.
- 1 October 2019
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 518 (2) , 253-258
Nac1 facilitates pluripotency gene activation for establishing somatic cell reprogramming
- 1 October 2019
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 518 (2) , 253-258
Nac1 facilitates pluripotency gene activation for establishing somatic cell reprogramming
- 18 January 2013
- Published by Emerald Publishing in Microelectronics International
- Vol. 30 (1) , 33-39
Embedded passive device technology for wireless mobile devices
Purpose: The purpose of this paper is to present the design and manufacture of embedded passive devices in organic substrates.Design/methodology/approach: Low cost and high performance duplexers have been designed for WiMAX front‐end modules with multi‐layered organic substrates. Band‐pass filters (BPFs) and duplexers for the WiMAX FEM have been embedded in organic substrates. In addition, a new organic substrate manufacturing process has been proposed in order to improve the tolerance of embedded passives in organic substrates.Findings: The overall size of FEM, which includes PA and bypass capacitor, is 5.4×4×1.5 mm. BPFs and duplexer show good electrical performances with low insertion loss and high attenuation. The dual‐band FEM with embedded passive components incorporates the duplexers including 2 and 5 GHz BPFs. The dimensions of BPFs and duplexer are 1.65×1.8×0.12 mm, 1.32×1.2×0.12 mm and 2×2×0.6 mm, respectively. The integrated dual‐band BPFs show an insertion loss < 1.8 dB in path band and 22‐40 dB attenuation performance in rejection band. The newly proposed fabrication process improves the tolerance for embedded capacitors in the organic substrate. This new process provides two main advantages. First, the flat coating process is not required. Second, it has a better copper pattern tolerance since the pattern is achieved with the addictive process. The tolerance of capacitances produced by the newly proposed process is compared with one manufactured by the conventional etching process. The newly proposed process provides a better capacitance tolerance.Research limitations/implications: In future studies, it is suggested that the tolerance study should include other variations such as thickness, alignment and material properties.Practical implications: The paper's findings can be used for designing and manufacturing embedded passives devices for wireless applications.Originality/value: This study shows a technology development in the area of embedded passive devices in organic substrates.
- 18 January 2013
- Published by Emerald Publishing in Microelectronics International
- Vol. 30 (1) , 33-39
Embedded passive device technology for wireless mobile devices
Purpose: The purpose of this paper is to present the design and manufacture of embedded passive devices in organic substrates.Design/methodology/approach: Low cost and high performance duplexers have been designed for WiMAX front‐end modules with multi‐layered organic substrates. Band‐pass filters (BPFs) and duplexers for the WiMAX FEM have been embedded in organic substrates. In addition, a new organic substrate manufacturing process has been proposed in order to improve the tolerance of embedded passives in organic substrates.Findings: The overall size of FEM, which includes PA and bypass capacitor, is 5.4×4×1.5 mm. BPFs and duplexer show good electrical performances with low insertion loss and high attenuation. The dual‐band FEM with embedded passive components incorporates the duplexers including 2 and 5 GHz BPFs. The dimensions of BPFs and duplexer are 1.65×1.8×0.12 mm, 1.32×1.2×0.12 mm and 2×2×0.6 mm, respectively. The integrated dual‐band BPFs show an insertion loss < 1.8 dB in path band and 22‐40 dB attenuation performance in rejection band. The newly proposed fabrication process improves the tolerance for embedded capacitors in the organic substrate. This new process provides two main advantages. First, the flat coating process is not required. Second, it has a better copper pattern tolerance since the pattern is achieved with the addictive process. The tolerance of capacitances produced by the newly proposed process is compared with one manufactured by the conventional etching process. The newly proposed process provides a better capacitance tolerance.Research limitations/implications: In future studies, it is suggested that the tolerance study should include other variations such as thickness, alignment and material properties.Practical implications: The paper's findings can be used for designing and manufacturing embedded passives devices for wireless applications.Originality/value: This study shows a technology development in the area of embedded passive devices in organic substrates.